{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2
  ],
  "modelUsed": "claude-opus-4-5",
  "metadata": {
    "studyName": "A Single-Dose, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Way Crossover Study to ",
    "titles": [
      {
        "id": "title_1",
        "text": "A Single-Dose, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Way Crossover Study to Evaluate the Effect of Evobrutinib on the QTc (Corrected QT) Interval in Healthy Adult Participants",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "A TQT Study of Effect of Evobrutinib on Cardiac Repolarization",
        "type": {
          "code": "Brief Study Title",
          "codeSystem": "USDM",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "MS200527_0070",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "2022-002664-78",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Merck KGaA, Darmstadt, Germany",
        "type": {
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "decode": "Pharmaceutical Company"
        },
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "Merck Healthcare KGaA, Darmstadt, Germany",
        "type": {
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "decode": "Pharmaceutical Company"
        },
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "EMD Serono Research & Development Institute, Inc.",
        "type": {
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "decode": "Pharmaceutical Company"
        },
        "instanceType": "Organization"
      }
    ],
    "roles": [],
    "indications": [
      {
        "id": "ind_1",
        "name": "Cardiac Repolarization Assessment",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Evaluation of the effect of Evobrutinib on the QTc interval in healthy adult participants"
      }
    ],
    "studyPhase": {
      "code": "Phase1",
      "codeSystem": "USDM",
      "decode": "Phase1"
    },
    "studyType": "Interventional"
  },
  "rawResponse": {
    "titles": [
      {
        "id": "title_1",
        "text": "A Single-Dose, Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Way Crossover Study to Evaluate the Effect of Evobrutinib on the QTc (Corrected QT) Interval in Healthy Adult Participants",
        "type": {
          "code": "OfficialStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "A TQT Study of Effect of Evobrutinib on Cardiac Repolarization",
        "type": {
          "code": "BriefStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "MS200527_0070",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "2022-002664-78",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Merck KGaA, Darmstadt, Germany",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "Merck Healthcare KGaA, Darmstadt, Germany",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "EMD Serono Research & Development Institute, Inc.",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "instanceType": "Organization"
      }
    ],
    "studyPhase": {
      "code": "Phase1",
      "codeSystem": "http://www.cdisc.org/USDM/studyPhase",
      "decode": "Phase 1"
    },
    "studyType": "Interventional",
    "indication": {
      "id": "ind_1",
      "name": "Cardiac Repolarization Assessment",
      "description": "Evaluation of the effect of Evobrutinib on the QTc interval in healthy adult participants",
      "instanceType": "Indication"
    }
  }
}